Komipharm International Co., Ltd. (KOSDAQ:041960)

South Korea flag South Korea · Delayed Price · Currency is KRW
7,620.00
-170.00 (-2.18%)
May 20, 2026, 3:30 PM KST
Market Cap551.25B +55.7%
Revenue (ttm)52.47B -10.7%
Net Income-7.21B
EPS-101.91
Shares Out72.34M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume250,084
Average Volume308,861
Open7,790.00
Previous Close7,790.00
Day's Range7,080.00 - 7,800.00
52-Week Range4,960.00 - 10,790.00
Betan/a
RSI31.12
Earnings DateApr 2, 2026

About Komipharm International

A South Korea–based biopharmaceutical company engaged in the development and manufacture of veterinary vaccines and veterinary pharmaceuticals. Its product line includes vaccines for animals—such as swine, cattle, poultry, and canines—as well as antibiotics, disinfectants, bio-fertilizers, and clinical lab services. The company is also developing anticancer drugs and pain-relieving agents for human health. [Read more]

Industry Medical - Pharmaceuticals
Sector Healthcare
Founded 1972
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 041960
Full Company Profile

Financial Performance

Financial Statements